Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ballantyne

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|September 22, 2006
Practical methods for supercoiled pNDA productionJohn Ballantyne
Vaccine|July 30, 2013
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)Jay W Hooper, Matthew Josleyn, John Ballantyne, et al.
Plos One|May 5, 2012
DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)Rebecca Brocato, Matthew Josleyn, John Ballantyne, et al.
Journal of Virology|January 22, 2016
Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic FeverJoseph W Golden, Piet Maes, Steven A Kwilas, et al.
Current Gene Therapy|May 29, 2014
A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primatesSteve Kwilas, Jennifer M Kishimori, Matthew Josleyn, et al.
Journal for Immunotherapy of Cancer|October 28, 2020
Endogenous HLA-DQ8αβ programs superantigens (SEG/SEI) to silence toxicity and unleash a tumoricidal network with long-term melanoma survivalPeter Knopick, David Terman, Nathan Riha, et al.
Human Vaccines & Immunotherapeutics|July 24, 2013
Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?Anne S De Groot, Leo Einck, Leonard Moise, et al.
Virology Journal|September 22, 2011
Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus diseaseJoseph W Golden, Marina Zaitseva, Senta Kapnick, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|July 24, 2024
Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screeningFrances McGill, Paul J Fields, Aví Bahadoor-Yetman, et al.
Journal of Virology|December 1, 2021
A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol ChallengeEric M Mucker, Joseph W Golden, Christopher D Hammerbeck, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|September 22, 2006
Practical methods for supercoiled pNDA productionJohn Ballantyne
Vaccine|July 30, 2013
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)Jay W Hooper, Matthew Josleyn, John Ballantyne, et al.
Plos One|May 5, 2012
DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)Rebecca Brocato, Matthew Josleyn, John Ballantyne, et al.
Journal of Virology|January 22, 2016
Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic FeverJoseph W Golden, Piet Maes, Steven A Kwilas, et al.
Current Gene Therapy|May 29, 2014
A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primatesSteve Kwilas, Jennifer M Kishimori, Matthew Josleyn, et al.
Journal for Immunotherapy of Cancer|October 28, 2020
Endogenous HLA-DQ8αβ programs superantigens (SEG/SEI) to silence toxicity and unleash a tumoricidal network with long-term melanoma survivalPeter Knopick, David Terman, Nathan Riha, et al.
Human Vaccines & Immunotherapeutics|July 24, 2013
Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?Anne S De Groot, Leo Einck, Leonard Moise, et al.
Virology Journal|September 22, 2011
Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus diseaseJoseph W Golden, Marina Zaitseva, Senta Kapnick, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|July 24, 2024
Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screeningFrances McGill, Paul J Fields, Aví Bahadoor-Yetman, et al.
Journal of Virology|December 1, 2021
A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol ChallengeEric M Mucker, Joseph W Golden, Christopher D Hammerbeck, et al.
Pageof 2